Cost Of Erythropoietin Use In The Early Access Program Of Telaprevir For The Treatment Of Metavir F3-F4 Patients With Genotype 1 Hcv In Brazil
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1583
https://www.valueinhealthjournal.com/article/S1098-3015(14)01634-9/fulltext
Title :
Cost Of Erythropoietin Use In The Early Access Program Of Telaprevir For The Treatment Of Metavir F3-F4 Patients With Genotype 1 Hcv In Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01634-9&doi=10.1016/j.jval.2014.03.1583
First page :
A272
Section Title :
Infection
Open access? :
No
Section Order :
1071